Epsilon Healthcare Ltd (EPN) - Total Liabilities

Latest as of December 2025: AU$14.88 Million AUD ≈ $10.53 Million USD

Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has total liabilities worth AU$14.88 Million AUD (≈ $10.53 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Epsilon Healthcare Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Epsilon Healthcare Ltd's total liabilities have evolved over time, based on quarterly financial data. See Epsilon Healthcare Ltd (EPN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Epsilon Healthcare Ltd Competitors by Total Liabilities

The table below lists competitors of Epsilon Healthcare Ltd ranked by their total liabilities.

Company Country Total Liabilities
New Age Exploration Ltd
AU:NAE
Australia AU$497.77K
Pollen Street PLC
LSE:POLN
UK GBX254.53 Million
WH Smith PLC
LSE:SMWH
UK GBX1.29 Billion
Nitro Games Oyj
ST:NITRO
Sweden Skr4.05 Million
ICDS Limited
NSE:ICDSLTD
India Rs30.58 Million
JPMorgan Claverhouse Investment Trust Plc
LSE:JCH
UK GBX40.51 Million
Auction Technology Group PLC
LSE:ATG
UK GBX250.77 Million
Great Western Exploration Ltd
AU:GTE
Australia AU$247.30K

Liability Composition Analysis (2016–2025)

This chart breaks down Epsilon Healthcare Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Epsilon Healthcare Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.98 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.83 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epsilon Healthcare Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual total liabilities of Epsilon Healthcare Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 AU$14.88 Million
≈ $10.53 Million
+28.63%
2024-12-31 AU$11.57 Million
≈ $8.18 Million
+68.29%
2023-12-31 AU$6.87 Million
≈ $4.86 Million
-38.80%
2022-12-31 AU$11.23 Million
≈ $7.95 Million
+2.27%
2021-12-31 AU$10.98 Million
≈ $7.77 Million
-8.06%
2020-12-31 AU$11.94 Million
≈ $8.45 Million
+117.47%
2019-12-31 AU$5.49 Million
≈ $3.89 Million
+17.90%
2018-12-31 AU$4.66 Million
≈ $3.30 Million
+691.15%
2017-12-31 AU$588.83K
≈ $416.63K
+403.30%
2016-12-31 AU$116.99K
≈ $82.78K
--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$6.06 Million
AU$8.56 Million AUD
Market Cap Rank
#28184 Global
#1483 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.04
All Time High
AU$1.08
About

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturi… Read more